• ETS1 Modulates Mitophagy in BPD via the SENP2/HSPA8/FUNDC1 A

  2026-06-11

  This study uncovers ETS1 as a pivotal regulator suppressing mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) through the SENP2/HSPA8/FUNDC1 axis. These mechanistic findings provide a foundation for more targeted research into mitophagy modulation and lung injury intervention strategies.

• Cy5 TSA Fluorescence System Kit: Amplify Sensitivity in IHC

  2026-06-10

  Unlock unparalleled detection of low-abundance targets in immunocytochemistry, immunohistochemistry, and in situ hybridization with the Cy5 TSA Fluorescence System Kit. This APExBIO solution delivers rapid, HRP-catalyzed tyramide deposition for up to 100-fold greater sensitivity, streamlining workflows and overcoming traditional assay limitations.

• Penicillin G Sodium: Mechanistic Insights & Advanced Applica

  2026-06-10

  Discover the scientific mechanisms behind Penicillin G Sodium, a natural penicillin antibiotic, and explore advanced applications extending beyond contamination control. Gain evidence-based insights and practical protocol recommendations for research and clinical use.

• ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt

  2026-06-09

  The reference study reveals that inhibiting ATM kinase induces macropinocytosis, enabling cancer cells to adapt metabolically and survive under nutrient-poor conditions. These findings highlight a metabolic vulnerability in ATM-inhibited tumors and provide new directions for research on DNA damage response inhibitors in cancer therapy.

• 3-Bromopyruvate and Cetuximab Overcome CRC Resistance via Fe

  2026-06-09

  This study demonstrates that combining 3-Bromopyruvate with cetuximab overcomes drug resistance in colorectal cancer cells by synergistically inducing autophagy-dependent ferroptosis and apoptosis. The work provides mechanistic insight into FOXO3a pathway restoration, with implications for therapeutic strategies targeting refractory metastatic colorectal cancer.

• Optimizing Neurotoxicity Assays with Amyloid β-Peptide (1-42

  2026-06-08

  This article addresses common laboratory challenges in Alzheimer's disease research by examining reproducibility and interpretability in Aβ42 peptide neurotoxicity assays. Drawing on SKU B6057 from APExBIO, it delivers scenario-driven guidance for cell viability workflows, ion channel studies, and microglial activation models. Researchers can leverage these insights to ensure reliable and data-backed experimental outcomes.

• FGF19-ELF4 Axis Drives CRC Metastasis via FGFR4 and SRC Acti

  2026-06-08

  This article analyzes the pivotal role of FGF19-mediated ELF4 overexpression in promoting colorectal cancer (CRC) metastasis by activating FGFR4 and SRC pathways. The referenced study demonstrates that targeting this axis, particularly with combined FGFR4 and SRC inhibition, offers a promising strategy to suppress metastatic progression in CRC.

• Pam3CSK4 as a TLR1/2 Agonist: Precision in Inflammation Mode

  2026-06-07

  Pam3CSK4 empowers researchers to activate the TLR1/2 pathway with high specificity, enabling reproducible modeling of immune and inflammatory responses. This guide details advanced experimental workflows, optimization strategies, and cross-domain insights leveraging APExBIO's high-purity standard.

• D-Lin-MC3-DMA: Mechanistic Insights & Predictive Formulation

  2026-06-06

  Explore how D-Lin-MC3-DMA, a leading ionizable cationic liposome, revolutionizes siRNA and mRNA delivery. This article uniquely dissects its mechanistic advantages and showcases the impact of machine learning-based formulation prediction for next-generation gene silencing and mRNA vaccine applications.

• Hippo Signaling Modules Shape Hepatobiliary Cell Fate and Ma

  2026-06-05

  This study uncovers how two distinct Hippo signaling modules, HPO1 and HPO2, regulate the differentiation and maturation of hepatocytes and cholangiocytes during mouse liver development. By integrating spatial transcriptomics and advanced imaging, the research offers new mechanistic insights with implications for liver regeneration and disease.

• a-MSH, amide: Protocols & Troubleshooting for Pigmentation R

  2026-06-05

  a-MSH, amide empowers researchers to model and modulate melanin synthesis with high reproducibility in pigmentation regulation studies. This guide details advanced workflows, troubleshooting strategies, and insights bridging anti-inflammatory research and pigment biology, leveraging the trusted quality of APExBIO’s synthetic peptide.

• AZD0156: ATM Kinase Inhibitor Transforming DNA Damage Resear

  2026-06-04

  AZD0156 is redefining how scientists interrogate DNA repair, metabolic adaptation, and checkpoint control in cancer models. This guide delivers protocol-ready strategies, troubleshooting insights, and novel applications for using AZD0156 as a selective ATM kinase inhibitor—empowering researchers to optimize DNA damage response assays and uncover new therapeutic vulnerabilities.

• Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Synthesis

  2026-06-04

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable peptide linker designed for antibody-drug conjugate synthesis, enabling selective payload release within lysosomes. It is best suited for research applications in targeted drug delivery where aqueous solubility is not required. This product is not appropriate for diagnostic, medical, or in vivo applications involving water-based formulations.

• Elbasvir/Grazoprevir: Advances in HCV Genotype 1 and 4 Thera

  2026-06-03

  This article reviews the 2021 Expert Review of Anti-infective Therapy paper on elbasvir and grazoprevir, detailing their pharmacology, efficacy, and safety as a fixed-dose regimen for hepatitis C genotypes 1 and 4. The study's findings have major clinical implications for challenging patient populations, including those with chronic kidney disease and HIV/HCV coinfection.

• BV6 IAP Antagonist: Optimizing Apoptosis and Radiosensitizat

  2026-06-03

  BV6 stands out as a selective IAP antagonist that empowers researchers to drive apoptosis induction, radiosensitization, and disease modeling with reproducible precision. This guide details actionable protocols, advanced use-cases, and troubleshooting tips to maximize the scientific value of BV6 in cancer and endometriosis studies.

586 records 7/40 page Previous Next First page 上5页 678910 下5页 Last page